Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 361,231,000	$ 365,623,000	$ 371,198,000	$ 289,070,000	$ 223,466,000	$ 230,213,000	$ 234,396,000	$ 218,826,000	$ 1,387,122,000	$ 906,901,000	$ 866,427,000
Restructuring expense									(25,628,000)	(6,869,000)	(23,683,000)
Business acquisition and integration expense									(53,198,000)	(31,593,000)	0
Gain on sale of assets									0	0	4,779,000
Total consolidated operating income	44,529,000	$ 33,264,000	$ 24,734,000	$ (22,063,000)	27,076,000	$ 35,961,000	$ 29,064,000	$ 25,951,000	80,464,000	118,052,000	110,067,000
Net other (expense) income									(125,528,000)	(34,633,000)	94,919,000
Total consolidated (loss) income from continuing operations before income taxes									(45,064,000)	83,419,000	204,986,000
Total Consolidated Assets	3,029,175,000				3,084,843,000				3,029,175,000	3,084,843,000	2,258,058,000
Total Consolidated capital expenditures									31,054,000	39,881,000	39,605,000
Total consolidated depreciation expense									44,574,000	33,888,000	32,278,000
Total consolidated intangible asset amortization expense									97,274,000	0	0
Discontinued Operations, Held-for-sale [Member]
Segment Reporting Information [Line Items]
Total Consolidated Assets					579,912,000					579,912,000	581,864,000
Chamberlain [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue									557,536,000	563,814,000	511,655,000
Total Consolidated Assets	293,461,000				484,110,000				293,461,000	484,110,000	483,563,000
Total Consolidated capital expenditures									15,235,000	28,631,000	19,920,000
Total consolidated depreciation expense									18,547,000	16,123,000	14,869,000
Walden University
Segment Reporting Information [Line Items]
Total Consolidated Revenue									485,393,000
Total Consolidated Assets	1,685,918,000								1,685,918,000
Total Consolidated capital expenditures									5,393,000
Total consolidated depreciation expense									9,255,000
Total consolidated intangible asset amortization expense									97,274,000
Medical and Veterinary [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue									344,193,000	343,087,000	354,772,000
Restructuring expense									(9,791,000)		(1,416,000)
Total Consolidated Assets	708,265,000				773,168,000				708,265,000	773,168,000	748,388,000
Total Consolidated capital expenditures									3,277,000	4,121,000	5,414,000
Total consolidated depreciation expense									13,890,000	14,431,000	14,195,000
Home Office and Other
Segment Reporting Information [Line Items]
Restructuring expense									(8,946,000)	(6,869,000)	(21,976,000)
Total Consolidated Assets	$ 341,531,000				$ 1,247,653,000				341,531,000	1,247,653,000	444,243,000
Total Consolidated capital expenditures									7,149,000	7,129,000	14,271,000
Total consolidated depreciation expense									2,882,000	3,334,000	3,214,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items									271,320,000	156,514,000	128,971,000
Operating Segments [Member] | Chamberlain [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items									127,252,000	128,851,000	99,652,000
Operating Segments [Member] | Walden University
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items									105,732,000
Operating Segments [Member] | Medical and Veterinary [Member]
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items									74,428,000	67,852,000	68,092,000
Operating Segments [Member] | Home Office and Other
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items									(36,092,000)	(40,189,000)	(38,773,000)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Deferred revenue adjustment									(8,561,000)
CEO transition costs									(6,195,000)
Restructuring expense									(25,628,000)	(6,869,000)	(23,683,000)
Business acquisition and integration expense									(53,198,000)	$ (31,593,000)
Gain on sale of assets											$ 4,779,000
Total consolidated intangible asset amortization expense									$ (97,274,000)